CXCR3 Antibody

NSJ Bioreagents
Product Code: NSJ-R31506
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-R31506-100ug100 ug£535.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: Rabbit IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
  • Human
  • Rat
Applications:
  • Immunohistochemistry- Paraffin Embedded (IHC-P)
  • Western Blot (WB)
Storage:
After reconstitution, the CXCR3 antibody can be stored for up to one month at 40. For long-term, aliquot and store at -200. Avoid repeated freezing and thawing.

Images

1 / 4
Western blot testing of CXCR3 antibody and Lane 1: COLO320; 2: SGC lysate. Predicted molecular weight ~41 kDa.
2 / 4
IHC-P: CXCR3 antibody testing of human lung cancer tissue
3 / 4
IHC-P: CXCR3 antibody testing of human tonsil tissue
4 / 4
IHC-P: CXCR3 antibody testing of rat kidney tissue

Western blot testing of CXCR3 antibody and Lane 1: COLO320; 2: SGC lysate. Predicted molecular weight ~41 kDa.
IHC-P: CXCR3 antibody testing of human lung cancer tissue
IHC-P: CXCR3 antibody testing of human tonsil tissue
IHC-P: CXCR3 antibody testing of rat kidney tissue

Further Information

Application Details :
Western blot: 0.5-1ug/ml,Immunohistochemistry (FFPE): 0.5-1ug/ml
Application Note:
The stated application concentrations are suggested starting amounts. Titration of the CXCR3 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Description:
CXCR3 is a Galphai protein-coupled receptor in the CXC chemokine receptor family. Other names for CXCR3 are G protein-coupled receptor 9 (GPR9) and CD183. CXCR3 is expressed on malignant B cells from chronic lymphoproliferative disorders, particularly in patients with CLL, and represents a fully functional receptor involved in chemotaxis of malignant B lymphocytes. It is found that in the absence of known etiologic agents, CXCR3 represents a novel target for therapeutic interference early in type 1 diabetes. Signaling is associated with MG pathogenesis and CXCR3 may serve as novel drug targets to treat MG. CXCR3A and CXCR3B are involved in the chemotactic and vascular effects of CXCL4L1.
Format :
Antigen affinity purified
Formulation :
0.5mg/ml if reconstituted with 0.2ml sterile DI water
Gene ID #:
2833
Immunogen:
Human partial recombinant protein (AA 1-368) was used as the immunogen for this CXCR3 antibody.
Limitation:
This CXCR3 antibody is available for research use only.
Purity:
Antigen affinity
Species Reactivity :
Human, Rat